MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Huntingtons disease"

  • 2017 International Congress

    Large CAG expansions in Huntington disease children: the RAREST-JHD initiative

    F. Squitieri, M. Marano, S. Migliore, S. Maffi, F. consoli, E. Bidollari, J. Rosati, A. Ciammola, E. Gatto, E. Cortes, A. Ilari, J. Vonsattel, U. Sabatini (Rome, Italy)

    Objective: RAREST-JHD (Juvenile Huntington Disease) is an initiative to study young HD subjects’ clinics, genetics and imaging to identify markers to transfer into clinics and…
  • 2017 International Congress

    Evaluating wearable sensors for objective measurement of motor features in Parkinson disease and Huntington disease – a pilot study

    J. Adams, M. Xiong, K. Dinesh, C. Tarolli, S. Sharma, N. Sheth, A.J. Aranyosi, W. Zhu, S. Goldenthal, K. Biglan, R. Dorsey, G. Sharma (Rochester, NY, USA)

    Objective: Evaluate the feasibility of wearable sensors in measuring motor features of individuals with PD, HD, prodromal HD, and controls in clinic and at home.…
  • 2017 International Congress

    A retrospective analysis of clinical forms and age of onset of biallelic Huntington disease patients from an Argentinean Center

    M. Cesarini, V. Parisi, G. Persi, J. Etcheverry, A. Sanguinetti, F. Squitieri, E. Gatto (Buenos Aires, Argentina)

    Objective: To compare AO and clinical presentation in Argentinean bi-allelic (BHD) patients, ie one mutated allele and one either intermediate (IA, 27-35 CAG repeats) or…
  • 2017 International Congress

    Update on the MDS-Sponsored Systematic Review On Clinical Rating Scales for Huntington’s Disease: motor, cognitive, functional ability and quality of life domains

    T. Mestre, C. Sampaio, C. Goetz, P. Martinez-Martin, G. Stebbins (Ottawa, ON, Canada)

    Objective: To provide an update on the MDS-sponsored Systematic Review of Rating Scales for Huntington’s Disease (HD).  Background: The use and validity of clinical rating…
  • 2017 International Congress

    Eye Movements in Huntington Disease Like 2

    D. Anderson, R. Margolis, A. Krause (Johannesburg, South Africa)

    Objective: ObjectiveTo determine if eye movements are preserved in Huntington Disease-Like 2 (HDL2) and if this can be used to differentiate HDL2 from Huntington Disease…
  • 2017 International Congress

    Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s Disease patients

    K.-H. Chang, Y.-R. Wu, C.-M. Chen (Taoyuan County, Taiwan)

    Objective: To determine whether the alterations of microRNA expression in central nervous tissues can be detected in peripheral leukocytes in Huntington's disease (HD) patients. Background: Huntington’s…
  • 2017 International Congress

    Longitudinal Study of Cortico-Striatal Functional Connectivity in Huntington’s Disease Measured with High-Field Functional MRI.

    M. Kronenbuerger, M. Kronenbuerger, J. Hua, X. Mia, P. Unschuld, P. van Zijl, C. Ross (Baltimore, MD, USA)

    Objective: To assessed functional connectivity by using functional Magnetic Resonance Imaging (fMRI) at 7 Tesla as baseline and one year thereafter. Background: Our previous study…
  • 2017 International Congress

    Generalized choreodystonia in a patient with HIV and hepatitis C with the history of opioid drug abuse after treating with interferon- 2alpha (Peginton)

    D. Khasanova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: We reported a case of a patient G., 47 years old treated with Pegintron (1,5 mcg/kg/week) and ribavirin (15 mg/kg/day) within a year due…
  • 2017 International Congress

    The neural correlates of apathy in premanifest and manifest Huntington’s disease: A cross-sectional multimodal imaging study

    S. Martinez-Horta, J. Perez-Perez, F. Sampedro, M. Carceller, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To delineate the brain correlates of apathy severity by means of glucose metabolism (18-FDG PET), grey-matter (GM) and white-matter (WM; FA-DTI) changes and relations…
  • 2017 International Congress

    Gait Analysis in Patients with Huntington’s Disease

    Y.-M. Park, S. Pyo, H.-M. Lee, M.-J. Kim, S.-B. Koh (Seoul, Republic of Korea)

    Objective: The aim of this study is to investigate the temporospatial gait parameters in patients with HD in comparison with healthy control. Background: Gait disturbance…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley